Heart failure (HF) is a debilitating disease with 26 million patients worldwide. Consistent and complex self-care is required on the part of patients to adequately adhere to medication and to the lifestyle changes the disease necessitates. Mobile health (mHealth) is being increasingly incorporated in patient interventions in HF, as smartphones prove ideal platforms for patient education and self-help assistance. This systematic review aims to summarize and report on all studies that have tested the effect of mHealth on HF patient outcomes. Our search yielded seventeen (17) studies, 11 RCTs and 6 non-randomized prospective studies. In these, patients with the assistance of an mHealth intervention regularly measured their blood pressure and/or body weight, as well as assessed their symptoms. The outcomes were mostly related to hospitalizations, clinical biomarkers, patients’ knowledge about HF, quality of life (QoL) and quality of self-care. QoL consistently increased in patients that received mHealth interventions, while study results on all other outcomes were not as ubiquitously positive. The first mHealth interventions in HF were not universally successful in improving patient outcomes but provided valuable insights about patient-oriented app development. Future trials are expected to capitalize on these gains and deploy apps that measurably assist HF patients.

心力衰竭 (HF) 是一种使人衰弱的疾病，全世界有 2600 万患者。患者需要持续而复杂的自我护理，以充分坚持药物治疗和疾病所需的生活方式改变。随着智能手机被证明是患者教育和自助协助的理想平台，移动医疗 (mHealth) 越来越多地融入心力衰竭患者干预中。本系统综述旨在总结和报告所有测试移动医疗对心力衰竭患者预后影响的研究。我们的检索产生了十七 (17) 项研究、11 项随机对照试验和 6 项非随机前瞻性研究。在这些研究中，患者在移动医疗干预的帮助下定期测量血压和/或体重，并评估他们的症状。结果主要与住院情况、临床生物标志物、患者对心力衰竭的了解、生活质量（QoL）和自我护理质量有关。接受移动医疗干预的患者的生活质量持续提高，而所有其他结果的研究结果并不普遍积极。首次针对心力衰竭的移动医疗干预措施在改善患者治疗效果方面并未取得普遍成功，但为以患者为导向的应用程序开发提供了宝贵的见解。未来的试验预计将利用这些成果并部署可显着帮助心力衰竭患者的应用程序。